AstraZeneca, Handa Settle Seroquel Patent Fight
Under the agreement, AstraZeneca will license Handa to enter the U.S. market with a generic version of Seroquel XR on Nov. 1, 2016. AstraZeneca's patents for the drug range in expiration dates from March 2012 to November 2017.
"We believe this agreement reaffirms our intellectual property rights and is the...
Already a subscriber? Click here to login